XENE Q4 2022 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$43M

Net Income

-$37M

EPS (Diluted)

$-0.57

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$754M

Total Liabilities

$33M

Stockholders' Equity

$721M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$4M	-100.0%
Gross Profit	$0	-$18M	+100.0%
Operating Income	-$43M	-$25M	-74.5%
Net Income	-$37M	-$26M	-46.3%